Michael Harsh - 21 Jan 2026 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Director
Signature
/s/ Michael Harsh by Mark Busch, attorney-in-fact
Issuer symbol
NDRA
Transactions as of
21 Jan 2026
Net transactions value
$0
Form type
4
Filing time
23 Jan 2026, 19:43:37 UTC
Previous filing
01 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Harsh Michael Director C/O ENDRA LIFE SCIENCES INC., 3600 GREEN COURT, SUITE 350, ANN ARBOR /s/ Michael Harsh by Mark Busch, attorney-in-fact 23 Jan 2026 0001706155

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NDRA Common Stock Award $0 +60,324 +1120% $0.000000 65,710 21 Jan 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include unvested restricted stock units ("RSUs").
F2 Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2026.